VRE

8
VRE 051114 ICAN 2014 1 Andreas Voss, MD, PhD Controlling the spread of VRE and especially other MDRO may cause serious harm to my job security Advisory board, speaker fees & grants from 3M, bioMerieux, JD, Deb, AspeMx, Astra Zeneca, Milenium bioscience, … Everyone harbours enterococci in his/ her GItract Resistant to cephalosporines Most prevalent species: E. faecalis Low virulence UTI Abdominal infecMons CLABSI and endocardiMs “Big/resistant brother” of E. faecalis Amoxicillin/ampicillinresistant Recent shiY: E. faecalis E. faecium LocaMon (GI) unchanged Virulence unchanged SuscepMble to vancomycin E. faecium and (less frequent) E. faecalis other species less important It’s all about vanA en vanB, the other vangens are generally less important Certain clonal complex’s (CCs) trend to be more epidemic e.g. CC17 VRE does not equal VRE

description

VRE outbreak at ICAN Harare, Zimbabwe

Transcript of VRE

Page 1: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   1  

Andreas  Voss,  MD,  PhD  

¤   Controlling  the  spread  of  VRE  and  especially      other  MDRO  may  cause  serious  harm  to  my      job  security  

¤  Advisory  board,  speaker  fees  &  grants  from    3M,  bioMerieux,  JD,  Deb,  AspeMx,  Astra  Zeneca,  Milenium  bioscience,  …  

¤ Everyone  harbours  enterococci  in  his/her  GI-­‐tract  

¤ Resistant  to  cephalosporines  ¤ Most  prevalent  species:  E.  faecalis  ¤ Low  virulence  

– UTI  – Abdominal  infecMons  – CLA-­‐BSI  and  endocardiMs  

 

•  “Big/resistant  brother”  of  E.  faecalis  – Amoxicillin/ampicillin-­‐resistant  

– Recent  shiY:  E.  faecalis  à  E.  faecium  

•  LocaMon  (GI)  unchanged  

•  Virulence  unchanged  

•  SuscepMble  to  vancomycin  

•  E.  faecium  and  (less  frequent)  E.  faecalis  –  other  species  less  important  

•  It’s  all  about  vanA  en  vanB,  the  other  van-­‐gens  are  generally  less  important  

•  Certain  clonal  complex’s  (CCs)  trend  to  be  more  epidemic  e.g.  CC17  

•  VRE  does  not  equal  VRE  

Page 2: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   2  

Ears  june  2011  

Meningitis

Neonatal infection

sepsis

pneumonia

UTI

Surgical infection

Meningitis Meningitis Meningitis Meningitis Meningitis sepsis

Patient: underlying diseases, antibiotics, veel co-morbidity

meningitis

endocarditis

UTI

Wound infections

Intra-abd. infections

¤   Contact  isolaMon  ²   (preferably)  single  room  

²   own  toilet/bed-­‐pan,  …  

²   gloves  and  gown  ²   hand  hygiëne  

²   disinfec<on  of  environment  

¤   Not  one  reason,  but  the  consequence  of      mulMple,  small  factors  

     à  Swiss-­‐Cheese-­‐Accident  Model  

Page 3: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   3  

(hand)hygiene

antibiotics cleaning

Werk pressure

Maintenance

Bad luck (Hand) hygiene

antibiotics

cleaning

Work pressure

Maintenance

Bad luck

(Hand) hygiene

antibiotics

cleaning

Work pressure

Maintenance

Bad luck

VRE outbreak

¤   Bad  luck  ²   virulent  clone      

¤     High  Work  pressure  ²   mixing  personnel  from  different  wards,  trainees  

¤   Cleaning/disinfecMon  ²   vacant  responsibiliMes  

¤   Maintenance/technique  ²   bed-­‐pan  washers  not  sufficient  

¤   Discipline  en  behaviour  ²   basic  infecMon  control  (contact  isolaMon/flagging)  ²   hand  hygiene  

¤   Microbiology  

¤   Epidemiology  

¤   InfecMon  control  

¤   PoliMcs  &  communicaMon  

¤   AnMbioMc  stewardship  

¤   DecolonizaMon  

¤   Chrome-­‐agar  versus  standard  media  

¤   “Added  value”  Ampicillin-­‐MH-­‐boullion    

¤   MulMplex  PCR  on  clinical  materials  

¤   Determine  A0  value  of  the  outbreak  strain  

¤   Compare/evaluate  typingmethods    ²   MLST,  AFLP  

Page 4: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   4  

¤ Up  to  50%  of  ward  HCWs  =  trainees  

¤ Faulty  contact  isolaMon  

¤ Bad  hand  hygiene  &  lacking  adherence  to  basic  infecMon  control  measures  

¤ Flagged  paMents  not  isolated/cohorted    

¤ Bed-­‐pans  and  commodes  frequently  VRE+  

¤ High-­‐touch  surfaces  VRE+  

¤   Bedpan  VRE+  despite    washers  were  tested    and  validqted  !  

Not  our  model    

¤   Combined  value  of  temperature  and  Mme  

 Z      =    10C  (thermal  destrucMon  factor)  T      =    measured  temperature            =    Mme  for  disinfecMon  (sec)  

¤   Bed-­‐pan  washers  according  to  EU  norm  A60  ²   A60  =  the  effect  of  1  min  80°C    

¤   The  A0  values  A0  >  60    cleaning,  contact  with  intact  skin  A0  >600    semi  criMcal,  in  contact  with  non-­‐intact  skin  or  mucous            membranes  A0  >  A0  >3000    criMcal,  in  contact  with  sterile  Mssue,  high-­‐level  disinfecMon    

 

¤   Range  of  values!  ²   CWZ  A0  80  to  5000  (too  much  variaMon)  

¤ TesMng  did  not  follow  the  norms  ²   No  cold  start  tesMng  

¤   ValidaMon  of  measurements?    ²   detailed  knowledge  no  longer  present  in      service  company  

Page 5: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   5  

 ¤   A0  value  of  outbreak  strain:  =    160  (2  min,  80C)    

¤   Bed-­‐pans  visible  dirty:      A0  is  not  a  statement  about  being  clean  

¤   Roomservice  ¤   Roomservice-­‐plus  ¤   Registered  nurse  ¤   Nurse  asistant  ¤   Cleaning  

Even  if  you  think  you  know  it,  are  they  actually  doing  it?  

Page 6: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   6  

¤   Do  certain  anMbioMcs  select  for  VRE?  

¤   Which  anMbioMcs  are  used  in  your  paMent      populaMon?  

Antibiotics (AB):

•  chephalosporines, vancomycin, cipro

Selective Digestive tract Decontamination (SDD)

•  no proof that SDD increases prevalence of VRE ↑  

•   NL: 10 of 14 (71%) of VRE+ hospitals use SDD

CWZ:

•  93% ≥ 1 AB in the 3 months before first VRE+ culture

•  54% was on AB at the time of their first VRE+ culture

•  On average VRE+ patient received 2.85 (range 0-10) different ABs before their first VRE+ culture

0.9%  =  close  to  nothing  

¤   Does  your  hospital  has  an  A-­‐team?   ¤   Nothing  in  the  literature  

¤   Possible  intervenMons?  ²   probioMcs  ²   feces-­‐transplantaMon  ²   ban  of  certain  food    (eg.  no  chicken)  

 

Page 7: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   7  

•  Weekly audits including feedback

•  Are screening cultures* negative

•  Are bed pans visible clean à later dropped when switch to disposable bed-pans

•  Do HCWs regard HH-rules and show no mistakes during observation of contact isolation

•  Are all flagged patients actually in isolation (SR or cohort)

•  Only trained nurses taking care of VRE patients

* Weekly microbiological screening of the environment and all patients in affected units (n=8)

Ward   Cultures  (pats  &  en.)  

Cleaning   HH-­‐rules  &  isola<on  

Flagging/sor<ng  

Trained  HCWs  

A  

B  

C  

D  

E  

Reported  to  medical  head,  unit  manger,  head  nurse,  CEO  

….

cleaning   flagging   cleaning  

Week   Cultures  (pats  &  en.)  

Cleaning   HH-­‐rules  &  isola<on  

Flagging/sor<ng  

Trained  HCWs  

1  

2  

3  

4  

5  

6  

7  

….  

A  long  <me  

Twee  week  meeMng  with  CEO,  IC,  medical  head  and  unit  manager  !  

¤ VRE tiredness after a few months

¤ BC to get the disposable system (VernaCare)

¤ Continuing merging of units

¤ Financial pressure – no closure of wards

¤ Too much work – to little trained HCWs

Page 8: VRE

VRE   05-­‐11-­‐14  

ICAN  2014   8  

AYer  14  months,  450+  cases,  20.000  PCRs,  extra  cleaners,  new  products,  and  endless  audits  

International Society of Chemotherapy for Infection and Cancer

www.ischemo.org

…..…..to  advance  the  educa.on  and  the  science  of  therapy  of  infec.on    

•  AnM-­‐infecMve  pharmacology  

•  AnMmicrobials  of  the  Future  

•  AnMmicrobial  Stewardship    

•  AnMsepMcs    

•  Bone,  Skin  and  SoY  Tissue  InfecMons  

•  Clostridium  difficile  InfecMon  

•  Collateral  Effects  of  AnM-­‐infecMves  

•  Controlling  AnMmicrobial  Resistance  

•  Device  Related  InfecMons  and  Biofilm  

•  EndocardiMs  &  Blood  Stream  InfecMons  

•  Fungal  InfecMons  

•  HepaMMs  

•  Human-­‐Animal  Interface  in  AnMmicrobial  Resistance  

•  ImmunisaMons  and  Vaccines    

 

•  Infec<on  Control  

•  InfecMons  in  Catastrophic  Areas  

•  InfecMons  in  the  ICU  and  Sepsis  

•  Intra-­‐abdominal  InfecMon  

•  MRSA  

•  OPAT  

•  Streptococcal  InfecMons  

•  Tuberculosis    

•  Urinary  Tract  InfecMons    

•  Zoonoses  

•  AnMmicrobial  Stewardship  &  InfecMon  Control  African  Network  

 

hOps://www.surveymonkey.com/r/2XG8LV6